and prescription drugs
Professional content for visitors with qualification in medicine or pharmaceuticals This content is only accessible by using your personal password.Learn more
Our products are available in 60 countriesClick here to learn more
Our activities incorporate all areas in the pharmaceutical value chainClick here to learn more
One of the fundamental pillars of our strategy is innovation. We devote about EUR 50 million to research and development.Click here to learn more
Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October. In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products. Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.
Last year, our company joined the kestrel protection programme of the Őrség National Park. As a company committed to nature conservation, and engaged in production activities in the region, Egis also supported the "Give a Kestrel Family a Home" initiative.
Liskadventure: Egis was one of the sponsors of the economic simulation camp modelling the theory of the world-famous Hungarian economist Tibor Liska
In 2021, the most popular workplaces were ranked again by the job portal zyntern.hu - this time Egis finished in a podium position in the natural sciences category.
Our company has joined the special initiative „Plastic-free July” launched by the municipality of Kőbánya.
Egis Pharmaceuticals PLC, the manufacturer of Betadine® solution, sponsors the work of the Water Rescue Service of Hungary with HUF 5 million.
At Egis we regularly organize so called “Navigator Days” to help our new colleagues’ integration.
Egis’ products are available in 60 countries. Our portfolio consists of 617 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.Learn more about our products